Twist Bioscience
TWST
47 hedge funds and large institutions have $142M invested in Twist Bioscience in 2018 Q4 according to their latest regulatory filings, with 47 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
22.79% more ownership
Funds ownership: 0% → 22.79% (+23%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$27.8M |
| 2 |
JP Morgan Chase
New York
|
+$21.2M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$15.6M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$13.5M |
| 5 |
A
Apoletto
Road Town, Tortola,
British Virgin Islands
|
+$10.1M |
Top Sellers
TWST Hedge Fund Activity: Q4 2018 in Review
47 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q4 2018, worth a combined $142M.
Buyers outnumbered sellers: 47 funds opened new TWST positions and 0 closed out — a net gain of 47 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $27.8M.
- 47 institutional investors held Twist Bioscience (TWST) as of Q4 2018, up from 0 in Q3 2018.
- Funds reported $142M of Twist Bioscience stock for Q4 2018.
- 47 funds opened new Twist Bioscience positions in Q4 2018 and 0 closed out, a net change of +47 holders.
- The largest Twist Bioscience buyer in Q4 2018 was Fidelity Investments, an estimated $27.8M added.
Based on aggregated 13F filings for Q4 2018.